BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:XTR003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of XTR003\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07443696-653@assetmemo.bio
DTSTAMP:20261121T004023Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:XTR003: Phase 2 readout est. (NCT07443696)
DESCRIPTION:XTR003\, phase 2\, Heart Failure.\nStudy: PET Myocardial Fatty-
 acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocard
 ial Viability in Ischemic Cardiomyopathy\nEstimated primary completion: 31
  December 2026. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/xtr00
 3#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07
 443696
URL:https://assetmemo.bio/drug/xtr003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
